[HLA expression in human fetal bone marrow mesenchymal stem cells]

Area of Science:

• Immunology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Human fetal mesenchymal stem cells (MSCs) are crucial for tissue repair and immune modulation.
• Understanding their immunophenotype, particularly human leukocyte antigen (HLA) expression, is vital for therapeutic applications.
• Long-term culture and cytokine stimulation can alter MSC properties, impacting their clinical utility.

Purpose of the Study:

• To evaluate HLA expression in human fetal MSCs after prolonged culture.
• To investigate the impact of interferon-gamma (IFN-gamma) on HLA expression in these cells.
• To analyze the expression of specific HLA molecules (HLA-G and HLA-E) at the mRNA level.

Main Methods:

• Human fetal MSCs from 23-24 week fetuses were cultured and analyzed at passage 5 and passage 12.
• Flow cytometry was used to assess HLA class I (HLA-I) and HLA class II (HLA-II) expression before and after IFN-gamma treatment.
• RT-PCR was employed to detect HLA-G and HLA-E mRNA levels.

Main Results:

• Fetal MSCs exhibited high constitutive HLA-I expression (>50%) and very low HLA-II expression (<10%).
• IFN-gamma significantly enhanced both HLA-I and HLA-II expression in a time-dependent manner, with greater effects on earlier passage cells.
• HLA-G and HLA-E were detected at the mRNA level in human fetal MSCs.

Conclusions:

• Human fetal MSCs can be induced to express HLA class I and II antigens upon IFN-gamma stimulation.
• Prolonged cell culture may attenuate the responsiveness of MSCs to IFN-gamma.
• The constitutive expression of HLA-G and HLA-E mRNA suggests potential immune-privileged properties.